Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹32Cr
Food - Processing - Others
Rev Gr TTM
Revenue Growth TTM
16.22%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

DECCAN
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | 28.4 | 46.0 | 77.3 | 0.7 | 34.2 | 9.5 | 33.2 | 29.9 | 47.0 | 13.7 | -14.9 |
| 15 | 10 | 16 | 14 | 15 | 14 | 18 | 20 | 20 | 21 | 20 | 16 |
Operating Profit Operating ProfitCr |
| 4.7 | 7.1 | 6.0 | 8.0 | 4.3 | 5.7 | 5.8 | 2.9 | 2.9 | 3.4 | 8.0 | 9.9 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | | 50.0 | 80.0 | 215.2 | -51.9 | 20.0 | -1.9 | -73.6 | -7.7 | -33.3 | 71.7 | 614.3 |
| 1.7 | 2.7 | 3.1 | 3.5 | 0.8 | 2.4 | 2.8 | 0.7 | 0.6 | 1.1 | 4.3 | 5.8 |
| 0.2 | 0.2 | 0.3 | 0.3 | 0.1 | 0.2 | 0.3 | 0.1 | 0.1 | 0.1 | 0.4 | 0.4 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -1.8 | 35.7 | 32.7 | 25.7 | 8.8 |
| 32 | 28 | 43 | 56 | 72 | 77 |
Operating Profit Operating ProfitCr |
| 6.0 | 16.1 | 4.4 | 6.3 | 4.2 | 5.9 |
Other Income Other IncomeCr | 0 | -3 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 |
| 1 | 1 | 0 | 2 | 2 | 3 |
| 0 | 0 | 0 | 1 | 0 | 1 |
|
| | -17.3 | -5.1 | 387.6 | -22.4 | 95.9 |
| 1.1 | 1.0 | 0.7 | 2.5 | 1.5 | 2.8 |
| 0.3 | 0.2 | 0.2 | 0.8 | 0.5 | 0.9 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 16 | 16 | 17 | 20 | 23 | 25 |
| 61 | 61 | 65 | 75 | 82 | 84 |
Current Liabilities Current LiabilitiesCr | 13 | 10 | 12 | 8 | 16 | 26 |
Non Current Liabilities Non Current LiabilitiesCr | 3 | 3 | 3 | 4 | 3 | 3 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 66 | 68 | 76 | 88 | 106 | 120 |
Non Current Assets Non Current AssetsCr | 26 | 23 | 21 | 20 | 19 | 18 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | -1 | -7 | -13 | -6 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | 0 | 0 | 0 |
Financing Cash Flow Financing Cash FlowCr | 0 | 0 | 5 | 14 | 8 |
|
Free Cash Flow Free Cash FlowCr | 0 | -1 | -7 | -13 | -7 |
| 56.3 | -177.6 | -2,210.0 | -840.9 | -554.7 |
CFO To EBITDA CFO To EBITDA% | 10.8 | -10.7 | -344.8 | -334.6 | -204.0 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 46 | 56 | 47 | 56 | 40 |
Price To Earnings Price To Earnings | 117.6 | 170.2 | 152.8 | 37.8 | 34.6 |
Price To Sales Price To Sales | 1.4 | 1.7 | 1.0 | 0.9 | 0.5 |
Price To Book Price To Book | 0.6 | 0.7 | 0.6 | 0.6 | 0.4 |
| 21.4 | 10.2 | 24.0 | 14.8 | 11.8 |
Profitability Ratios Profitability Ratios |
| 45.4 | 56.8 | 44.5 | 37.3 | 36.7 |
| 6.0 | 16.1 | 4.4 | 6.3 | 4.2 |
| 1.1 | 1.0 | 0.7 | 2.5 | 1.5 |
| 0.8 | 0.9 | 0.7 | 2.4 | 1.6 |
| 0.5 | 0.4 | 0.4 | 1.6 | 1.1 |
| 0.4 | 0.4 | 0.3 | 1.4 | 0.9 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Deccan Health Care Limited (BSE: 542248), established in 1996, is a leading Indian fast-moving consumer wellness company specializing in science-backed nutraceuticals, preventive healthcare, and nutrition-led solutions. The company is purpose-driven, focusing on combating public health challenges—particularly iron deficiency and anemia—through accessible, culturally appropriate, and food-based interventions. With an integrated business model spanning R&D, manufacturing, branding, and distribution, DHCL operates across nutraceuticals, Ayurvedic, personal care, self-care, and NutriFoods segments.
---
### **Core Focus & Mission**
- **Mission:** To help consumers age gracefully, improve overall well-being, and prevent disease through innovative, natural, and scientifically validated wellness solutions.
- **Strategic Focus:** Inclusive health and wellness in rural India; affordable, high-quality nutrition; and preventive healthcare through dietary supplementation and lifestyle integration.
- **Public Health Alignment:** Active contributor to the Government of India’s **Anemia Mukt Bharat (AMB)** initiative, aiming to reduce anemia in women, children, and adolescents through scalable, food-based iron delivery.
---
### **Business Model & Operations**
#### **1. Integrated Value Chain Control**
DHCL maintains full control across:
- R&D (Innovation Hub in SIDCUL, Pantnagar, Uttarakhand)
- Manufacturing
- Branding (Nutridecc®, Organowild®, BE YOUNG, STAY YOUNG)
- Distribution (e-commerce, B2B, exports)
#### **2. Manufacturing Capabilities**
- **Facility:** 3,536 sq. m. GMP- and WHO-GMP-compliant manufacturing plant at SIDCUL, Pantnagar, Uttarakhand (established 2010).
- **Certifications:** ISO 9001:2015, FSSAI-licensed, compliant with DSHEA (USA) and Indian regulations.
- **Production Capacity (Monthly):**
- 456.25 million softgels
- 1,216.67 million hardgels
- 608,333 units of liquid orals
- 243.33 million tablets
- 212,916 units of external preparations
- **Dosage Forms:** Tablets, capsules, softgels, liquids, syrups, powders, creams, lotions, and specialized formulations.
- **Upcoming Expansion:** A new intermediary factory and upgraded packaging facilities are under development to meet rising demand.
---
### **Product Portfolio & Innovation**
- **Total Market-Ready Products:** 1,500+
- **Active SKUs:** 400+
- **In Development:** 173 new recipes/formulations
- **Key Brands:**
- **Nutridecc®:** Science-based, lifestyle-focused supplements targeting modern health issues (e.g., Digital Eye Strain, Brain Fog, Tech Neck, Burnout).
- **Organowild®:** Nutri-food and wellness line emphasizing organic, sustainable, and culturally resonant products (e.g., millet cookies, iron-enriched fruit bars).
- **BE YOUNG & STAY YOUNG:** E-commerce-driven brands, with BE YOUNG focused on Indian consumers and STAY YOUNG for international markets.
#### **Flagship Innovations (2023–2025)**
| Product | Launch Date | Key Features |
|--------|-------------|-------------|
| **Iron-Enriched Fruit Bar** | 2023–24 | Palatable, non-medicinal iron solution with high compliance, no GI side effects; used in AMB programs. |
| **Organowild Millet Cookies** | Dec 2023 | High-protein, nutrient-dense snacks aligned with International Year of Millets and eco-conscious trends. |
| **Organowild Natural Iron Mango Slice** | May 2024 | Tasty, bioavailable iron delivery for adolescents and women; strong market acceptance and regional expansion. |
| **7 Tulsi™ Extracts in Honey** | Aug 2020 | Immunity-boosting, easy-consumption product launched during the pandemic. |
- **Scientific Backing:** Products are developed using advanced technology licensed from **CSIR-IHBT**, with validation from WHO- and ICMR-approved tools (e.g., digital hemoglobinometers).
- **R&D Focus Areas:** Gut microbiome health, personalized nutrition, preventive micronutrients (Vitamins C/D, Omega-3s), and early-life nutrition.
---
### **Channels & Market Reach**
#### **1. E-Commerce & Direct-to-Consumer (D2C)**
- **Primary Platform:** [www.beyoungstore.com](http://www.beyoungstore.com) – hybrid B2B/B2C digital commerce platform.
- **Operations:** Manages end-to-end supply chain via **Home Shops** and **Wellness Consultants**.
- **Network (FY24):** 423+ wellness consultants, 23 home shops, serving 275,000+ consumers.
- **States Covered:** Rajasthan, Punjab, UP, Bihar, Jharkhand, Assam, Mizoram, Odisha, Maharashtra, Gujarat, Telangana, and expanding.
- **Digitization Goals:** Geotagging home shops, handheld sales devices, AI-driven demand-responsive supply chain.
#### **2. Branded Distribution**
- **Platforms:** Amazon, [www.otcfirst.in](http://www.otcfirst.in), and other online marketplaces.
- **Target:** Health-conscious, premium wellness consumers in Tier 1–3 cities.
#### **3. Private Label Manufacturing**
- **Clients:** House of Masaba (Lovechild), Modicare, Plus Plus Lifesciences, MRL Pharma, Pranasa Mediworld, Quora Pharmaceuticals.
- **Revenue Streams:** Commission, brokerage, and bulk manufacturing.
#### **4. Exports & International Expansion**
- **Current Export Markets:** Kenya, Nepal
- **Registration in Progress:** Nigeria, UAE, USA
- **Subsidiaries:**
- **DBL USA:** To distribute in USA, Canada, South America ($5M phased investment planned).
- **UAE Subsidiary:** In development for local inventory and sales.
- **Future Targets:** GCC, Africa, and North America.
---
### **Strategic Priorities (2024–2025)**
1. **Expand Export Markets & Strengthen Global Footprint**
2. **Deepen Domestic Penetration** in underserved and rural areas
3. **Scale Clinically Validated Products** with proven efficacy
4. **Enhance E-Commerce & Omnichannel Capabilities**
5. **Invest in Innovation & Personalized Nutrition** (AI, chatbot-based recommendations, data analytics)
6. **Support National Health Initiatives** (e.g., Anemia Mukt Bharat)
---
### **Key Initiatives & Collaborations**
- **Anemia Mukt Bharat Program:**
- Supplying iron-fortified products (e.g., Iron Mango Bars) to 600 schoolgirls in Telangana.
- Partnering with NGOs and government bodies.
- **Project BeYoungBharat:** D2C outreach program successfully launched (FY22–23) with home shop expansion and localized delivery.
- **Digital Health Tools:** Free chatbot on Nutridecc® website offering personalized nutrition advice for digital fatigue, burnout, and stress.
---
### **Corporate Leadership**
- **Dr. Minto Purshotam Gupta** – Founder, Promoter, Chairman & Managing Director
- PhD in Microbiology, Cellular Biochemistry (University of Mumbai)
- Over 25 years in nutraceuticals and preventive healthcare
- Former roles: Rallis India (TATA), Ranbaxy, SOL Pharmaceuticals, ICICI Bank, Idemitsu Kosan
- Developed 1,600+ nutraceutical recipes; delivered over 100 crore consumer doses
- **Meenakshi Gupta** – Promoter & Non-Executive Director
- Master’s in Science in Education Extension
- WHO-affiliated research in 1982; designed indigenous water filter
---
### **Financial & Operational Highlights**
- **Revenue (Apr 2022–Mar 2023):**
- ₹640.73 million from Beyoung Store (proprietorship)
- ₹613.08 million in commission/brokerage
- ₹0.62 million from international operations (Nepal)
- **Cost Efficiency:** Material and operating expenses at ~30% of revenue; strong cost control and pricing power.
- **Influencer Network:** ~463 active influencers (out of 600+ total pool); 10–15% traction rate; commission-based model.
- **Consumer Base:** Over 275,000 served via e-commerce; 6,000+ Product Information Personnel (PIPs) trained.
---
### **Sustainability & Innovation**
- **Sustainable Sourcing:** Organic and conventional raw materials; farm-to-factory supply chain.
- **Sustainable Formats:** Millet-based, plant-forward, low-waste packaging (sachets, stick packs, pouches, customizable options).
- **Environmental Compliance:** Effluent treatment plant in manufacturing unit; SOP-driven, GMP-compliant operations.